0000-00-00 |
|
|
|
External link to document |
2023-01-12 |
119 |
Opinion |
11,192,897 (the “’897 patent”), and 11,384,086 (the “’086
patent”).1 These patents are directed to crystalline…The
patents-in-suit are Patent Nos. 9,493,470 (the “’470 patent”), 11,192,895 (the
“’895 patent”), 11,192,897… 63)
’470 Patent = Patent No. 9,493,470 (DE 63-2)
’895 Patent = Patent No. 11,192,895 (DE…, and ’897 patents—was consolidated with Civil Action No. 1:22-cv-06151, a
parallel patent infringement…proceedings before the U.S. Patent and Trademark
Office that led to approval of the patent, can further illuminate |
External link to document |
2021-12-26 |
36 |
Answer to Amended Complaint |
. Apotex admits that U.S. Patent No. 11,192,897 (the “’897 patent”), issued on
December 7, 2021,… As to the Alleged Infringement of U.S. Patent No. 11,192,897 by Apotex
…THE PATENTS-IN-SUIT
6. Apotex admits that U.S. Patent No. 9,493,470 (the “’470 patent”), …purports to bring an action for patent
infringement under the patent laws of the United States, 35 U.…470 patent. Apotex further admits that what appears to be an uncertified
copy of the ’470 patent was |
External link to document |
2022-03-31 |
47 |
Letter |
Claim Construction of U.S. Patent Nos. 9,493,470, 11,192,895, and 11,192,897. (Attachments: # 1 Text of… 2021
8 February 2023
2:21-cv-12998
Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |